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ABSTRACT
The quest for inducers and inhibitors of protein
amyloidogenesis is of utmost interest, since they
are key tools to understand the molecular bases
of proteinopathies such as Alzheimer, Parkinson,
Huntington and Creutzfeldt–Jakob diseases. It is
also expected that such molecules could lead to
valid therapeutic agents. In common with the
mammalian prion protein (PrP), the N-terminal
Winged-Helix (WH1) domain of the pPS10 plasmid
replication protein (RepA) assembles in vitro into a
variety of amyloid nanostructures upon binding to
different specific dsDNA sequences. Here we show
that di- (S2) and tetra-sulphonated (S4) derivatives
of indigo stain dock at the DNA recognition interface
in the RepA-WH1 dimer. They compete binding of
RepA to its natural target dsDNA repeats, found at
the repA operator and at the origin of replication of
the plasmid. Calorimetry points to the existence of
a major site, with micromolar affinity, for S4-indigo
in RepA-WH1 dimers. As revealed by electron
microscopy, in the presence of inducer dsDNA,
both S2/S4 stains inhibit the assembly of RepA-WH1
into fibres. These results validate the concept that
DNA can promote protein assembly into amyloids
and reveal that the binding sites of effector mole-
cules can be targeted to inhibit amyloidogenesis.
INTRODUCTION
Aggregation of proteins into amyloid assemblies is
the conundrum of an increasing number of
proteinopathies with devastating impact on human
health. Although amyloids share related 3D structures,
the factors responsible for inducing protein amyloidogen-
esis are diverse (1). Among the latter, nucleic acid ligands
have been extensively studied for the mammalian prion
protein (PrP), the causative agent of lethal transmissible
spongiform amyloid encephalopathies (2). The conforma-
tion of the cellular form of this protein (PrP
c)i s
transformed into its pathogenic variant (PrP
sc) upon
binding to long, mixed DNA or RNA sequences in vitro,
promoting its assembly into amyloid ﬁbres and spheroids
(3–7). More recently, the interaction of PrP with a short,
speciﬁc dsDNA sequence has been characterized by NMR
spectroscopy (8) and the in vitro selection of small ssDNA
thioaptamers binding to PrP reported (9). The latter study
points to the existence in PrP of two DNA-binding sites,
one with high aﬃnity (speciﬁc) and another with lower
aﬃnity (non-speciﬁc) (9). The reports by Supattapone and
co-workers (10), on the strict requirement of polyanionic
additives for the successful ampliﬁcation in vitro of PrP
sc
from recombinant PrP and on the existence of a stable
complex constituted by several PrP molecules bound to
RNA/ssDNA (11), have the highest relevance for under-
standing prion amyloidogenesis.
RepA is a multifunctional DNA binding protein
encoded by the Pseudomonas pPS10 plasmid (12). RepA
dimers bind to repA gene operator repressing its own
transcription, whereas RepA monomers activate plasmid
replication after cooperative binding to four directly
repeated DNA sequences (termed iterons) (13). Single
iteron binding, by itself, enhances dissociation of RepA
dimers and induces a structural transformation (14,15) in
the N-terminal Winged-Helix dimerization domain (WH1)
(16) that implies the conversion of part of its a-helical
elements into b-strands and loops (17). Although stable
binding of RepA to dsDNA requires the presence of a
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WH2, when isolated, can bind to their targets at the
operator and iteron sequences (16). The conformational
changes experienced by RepA, paralleling those in known
amyloid forming proteins (1), have recently inspired a
search for conditions leading to RepA-WH1 amyloido-
genesis in vitro (18). Speciﬁc operator or iteron core
sequences (11bp), combined with point mutations in an
amyloidogenic sequence located opposite to the DNA-
binding interface (17), drive the assembly of the domain
into a range of amyloid nano-structures spanning from
irregular aggregates to well ordered ﬁbres, through regular
spheroids (18). The key determinant for the ﬁnal type of
assembly or ‘strain’ is the sequence of the dsDNA ligand
(operator for the ﬁbres), albeit DNA itself is not a
component of the matured amyloids (18). This suggests
that transient binding of a speciﬁc dsDNA to WH1 would
shield an electropositive patch at the DNA binding
interface, thus assisting the ordered assembly of the
protein into ﬁbres. The latter is achieved through a
cross-b spine made of the amyloidogenic peptide sequence
L26VLCAVSLI34, distal to the dsDNA-binding site (18).
RepA-WH1 provides a suitable and novel bacterial
model system to study sequence-speciﬁc DNA-promoted
protein amyloidogenesis. Here, we have searched for small
molecules docking in silico to RepA-WH1 and found
di- (S2) and tetra-sulphonated (S4) derivatives of the
classic indigo stain that compete with RepA binding
to dsDNA. The thermodynamic characterization of
S4-indigo interaction shows that it involves a major
binding site in WH1 (Kd=0.23mM). Inhibition by the
sulphonated indigoids of RepA-WH1 binding to the
operator dsDNA sequence abolishes ﬁbre assembly,
constituting a proof of concept for DNA-induced protein
amyloidogenesis (18). Unlike the wealth of small mole-
cules described so far to inhibit protein aggregation into
amyloids (19,20), those reported here are the ﬁrst acting at
the binding site for a regulator or enhancer of amyloido-
genesis, rather than at the peptide sequences directly
assembling into the landmark amyloid cross-b structure.
MATERIALS AND METHODS
Dockingof sulphonated indigoids toRepA-WH1
The chemical structures of indigo (3,30-dioxo-2,20-bis-
indole) and its 5,50-disulphonic (indigotine or indigo
carmine) and 5,50,7,70-tetrasulphonic derivatives were
outlined by using ChemDraw (v.10.0, CambridgeSoft)
and then exported to SMILES code. The 3D structures of
the molecules were generated by means of Corina
(http://www.molecular-networks.com/online_demos/corina_
demo.html) and saved as PDB ﬁles. Docking of the
indigoid molecules to the structure of RepA-WH1 dimer
(17; PDB code 1HKQ) was performed using AutoDock
(v.3.05) (21), run in an Apple workstation (2 2GHz
PowerPC G5, OSX 10.3.9). Being the indigo (bis-indolic)
core planar considerably simpliﬁes the ﬂexible docking of
the ligands, because it reduces the number of torsional
degrees of freedom that have to be taken into account to
those concerning the four (S2-indigo) or eight (S4-indigo)
substituent sulphate groups. Protein structure was
screened within a 50 50 50A ˚ cube centred at the
dimer interface and sampled with a grid in which points
were spaced 0.425A ˚ . Translation and rotation steps were
set to 1.5A ˚ and 258, respectively. A Lamarckian genetic
algorithm (mutation rate 0.02, crossover rate 0.8) was then
used for 25 runs in a population of 50 individuals. All the
solutions ﬁtted to the DNA binding interface in RepA-
WH1 (17). Independent runs placing the sampled volume
around other protein areas did not yield a solution with a
noticeable low G.
Protein purification and DNA synthesis
RepA-WT protein and its isolated WH1 domain,
either WT or carrying the amyloidogenic enhancing
mutation A31V, were puriﬁed as described (16,18).
Concentrated protein stocks were dialysed against 0.1M
Na2SO4, 20mM Tris–SO4 pH 8, 4mM MgSO4,1 m M
2-MeEtOH, 10% glycerol before long-term storage at
–708C. Protein concentration, determined by A280nm
(14,16), is expressed in a per-monomer basis. The dsDNA
oligonucleotide opsp (50-CATTGACTTGT/30-GTAACT
GAACA) (18) was synthesized and annealed (0.2mM
stock) as previously described (16). For the DNA binding
competition assays by indigoids, PCR was performed
using as templates pUC18 derivatives (0.1mg) carrying
either a 39bp sequence spanning the repA operator or
a 22bp single pPS10-oriV iteron, cloned into the vector
SmaI site (14,15). The universal primers f17 and r19
(50pmol each) were used in 40 cycles of ampliﬁcation by
gel-adsorbed Taq DNApol (BioTools). Ampliﬁed
dsDNAs were puriﬁed by means of phenol–chloroform–
isoamylic alcohol extraction plus ethanol precipitation.
Electrophoretic mobility shiftassays (EMSA)
Ten microlitre aliquots containing 35 pmol of RepA-WT
in protein buﬀer (see above) were incubated for 15min on
ice with serial dilutions of S2/S4-indigo (purchased from
TCI Europe, Belgium; 10mM stocks in water). Then the
operator or iteron dsDNAs (calibrated to be  50% bound
by RepA) were added and incubated for further 15min
on ice, before adding 2.5ml of 0.05% bromophenol
blue in 20% glycerol. Samples were immediately loaded
onto 6% polyacrylamide (29:1)–0.25 TBE minigels.
Electrophoresis was run at 150V, for 1h at 48C. After
ethidium bromide staining, bands were quantiﬁed by UV
detection (Bio-Rad Gel Doc 2000).
Isothermal titration calorimetry (ITC)
Six microlitre aliquots of a RepA-WH1-WT stock
(150mM) were extensively dialysed (5l total volume,
various changes for 48h) against 20mM Tris–HCl pH
8at 48C. A quantity of 1.8ml of the protein solution
(a concentration range spanning 75–100mM was tested
in several independent assays) were displayed into a
MicroCal VP-ITC (22), degassed for 5–10min and
equilibrated at 168C. The reference cell contained buﬀer
from the last dialysis passage. Twenty-ﬁve injections (10ml
each) of distinct concentrations (0.62–1.41mM, diluted in
dialysis buﬀer from a 10mM stock) of S2/S4-indigo were
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leaving 150s between injections to allow for equilibration.
Baselines were acquired (the buﬀer at the sample cell
titrated with S2/S4-indigo) and subtracted before integra-
tion of data. Calculation of the aﬃnity constants (Ka),
enthalpy (H) and stoichiometry (n) were performed,
according to pre-established binding models, by means of
non-linear regression best ﬁtting (23; equation 6b therein),
as implemented in the Origin-7 software (Microcal).
Transmission electron microscopy (TEM)
RepA-WH1-A31V (35mM) ﬁbres were assembled in the
presence of equimolar amounts of opsp-dsDNA as
described (18), with the only modiﬁcation of including
1-, 3- or 9-fold molar excess of S2/S4-indigo over protein
molecules in the incubations (48C for 1 month). TEM was
performed after negative staining (2% uranyl acetate)
using a JEOL JEM-1230 electron microscope, operating at
100kV (18).
RESULTS
Smallmolecules targeting the dsDNA bindingsurface in
RepA-WH1
The rationale for the selection of molecules inhibiting
RepA-WH1 interaction with dsDNA and thus protein
amyloidogenesis (18) was the following. Contacts of WH1
with the phosphate backbone of dsDNA are required for
the stable binding of RepA to the operator and iteron
sequences (16,24). Thus, the electropositive patch deﬁned
in the 3D structure of WH1 dimers (17) by the side
chains of arginine residues 78, 81, 91 and 93 (Figure 1)
would provide a pocket where an acidic ligand should
potentially bind. Since such Arg residues cluster around
Figure 1. Sulphonated indigo derivatives target the dsDNA binding interface in RepA-WH1. Left: the most symmetrically arranged docking
solutions for the acidic indigo derivatives (cyan) S2 (A) and S4 (B) on the pseudo-2-fold axis of the protein dimer (17; PDB entry 1HKQ; subunits in
yellow and green). The calculated values of G for docking and binding are displayed. Right: close-up views of the sulphonated indigos in
electrostatic interaction with the side chains of the Arg residues 78, 81 and 91. The guanidinium group of each Arg93 residue could make a cation-p
interaction with its nearest indol moiety that, together with H-bonding between the side chain of Asn77 and the pyrrolidin keto and amino groups,
would account for the Gdock predicted for the unmodiﬁed indigo molecule ( 5.54kcal/mol, data not shown). Models were rendered using PyMOL
(http://www.pymol.org).
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the candidate ligand should also exhibit that symmetry.
Therefore, a search for small, symmetric, acidic molecules
was carried out by visual inspection of the available
commercial catalogues. Up to 10 molecules following
these criteria, most of them di-carboxylates derived from
tartaric acid but also including two sulphonated variants
of the blue stain indigo, were tested in silico by docking to
the crystal structure of RepA-WH1 dimer (see Materials
and Methods section). Those with the best (lowest) G
values predicted were the S2 and S4-indigoids (Figure 1),
in particular the latter (Figure 1B). The enthalpic term,
provided by salt bridges between the electronegative
oxygens in the ligand sulphates and the electropositive
guanidinium groups in the protein Arg residues, is
expected to drive binding, thus tuning the speciﬁcity of
the interaction. The rigidity of the ligand core leaves the
overall entropic term of interaction to rely on the water
molecules/ions displaced upon binding.
The S2/S4-indigoids were then purchased and their
abilities to inhibit the binding of full-length RepA-WT
dimers to operator (Figure 2A) and a single iteron
(Figure 2B) dsDNA sequences (14–16) were tested
in vitro by means of electrophoretic mobility shift assays
(EMSA). Both indigoids completed the formation of
RepA-operator complexes, with an apparent IC50 between
50–100mM. In contrast, the tartrate ligand derivatives
mentioned earlier worked in a much poorer way (IC50
approaching to millimolar, data not shown). Being the
electric ﬁeld applied in EMSA disruptive for Coulombic
interactions in protein–ligand complexes, in particular
until these enter into the gel (15), the reported IC50 values
are likely overestimated. Besides this, we have not
observed any major diﬀerence in IC50 if the dyes were
added to the reaction mixture after pre-incubating protein
with dsDNA, suggesting Kd values for RepA-indigoids
binding in the order of those for the speciﬁc DNAs (16).
It is noteworthy that inhibition by both indigoids of RepA
binding to the iteron sequence seems to be less eﬃcient
than to the operator inverted repeat. As shown in
Figure 1, S2/S4-indigos are expected to bind to RepA
dimers (the species binding to the operator) but not to
RepA monomers (active in iteron binding), thus the dyes
would have on the latter only an indirect eﬀect, consisting
in shielding a fraction of the dimers from iteron-induced
dissociation into monomers (14,15). In addition, S2-indigo
has a net tendency to induce RepA aggregation (part of
the dye does not enter into the gel): this could have some
contribution to its competitor eﬀect on protein binding to
either dsDNA sequence, thus appearing to match the
more speciﬁc inhibitor S4-indigo.
Thermodynamics of S2/S4-indigos binding toRepA-WH1
Isothermal Titration Calorimetry (ITC; 23) was then used
to get a reliable measure of the binding constants and
overall energetics of the interactions between S2/S4
indigoids and RepA-WH1 dimers. The latter was used,
rather than full length RepA, due to its higher solubility
(16). The titrations performed with S4-indigo (Figure 3)
were exothermic, pointing to a major site (Kd=1/Ka=
0.23mM) with a single molecule bound per protein dimer
(ligand-to-protein monomer stoichiometry, n=0.69) (23),
as predicted by docking (Figure 1B). This high aﬃnity
protein–ligand interaction is enthalpy-driven (H=
 9.73kcal/mol; S= 0.003kcal/mol). The free energy
of binding calculated from the ITC measurements
(G=H–TS= 8.86kcal/mol) is close to that esti-
mated in the docking procedure (G= 9.19kcal/mol)
(Figure 1B), supporting the reliability of the latter.
A second transition became evident at the highest
concentration range of S4-indigo tested, probably reﬂect-
ing multiple and non-speciﬁc ligand binding (Kd=
23.3mM, n=1.43; approximately three molecules bound
per WH1 dimer; G=0.3kcal/mol), which results in
the formation of aggregates. We cannot exclude that
these non-speciﬁc binding sites in RepA-WH1 could
become available due to some structural change in the
protein induced by the primary S4-indigo binding event.
Figure 2. EMSA showing competition by S2/S4-indigos (1, 0.25 and 0.063mM) of the binding of RepA-WT to either a DNA fragment containing
the repA operator sequence (A) or a single iteron origin repeat (B). The positions of the free dsDNAs (f) and their complexes with RepA monomers
(m) and dimers (d) are indicated.
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determination of either aﬃnity constants or stoichiometry,
due to non-speciﬁc binding which also gave way to protein
aggregation.
S2/S4-indigos inhibit WH1-A31V assembly into amyloids
The ability of the S2/S4-indigo molecules to inhibit the
dsDNA-induced assembly of the hyper-amyloidogenic
WH1-A31V mutant into ﬁbres was then checked. In
summary, puriﬁed protein and dsDNA oligonucleotide
were incubated in the presence of equimolar amounts, or
3- or 9-fold molar excess, of the indigoid ligands for
a month, to allow for full maturation of the ﬁbres (18).
Samples were then inspected by means of transmission
electron microscopy (TEM) after negative staining
(Figure 4). In the control samples incubated in the absence
of either of the indigoid stains, bundles of long, 75nm
thick, amyloid ﬁbres (18), were evident (Figure 4A).
However, samples incubated with S2-indigo (up to 3:1
ligand-to-protein ratio) showed smaller and thinner
(ø=25nm) ﬁbres. These became even shorter and
curved at a higher molar ratio (9:1). When S4-indigo
was the molecule tested, the result was very similar to that
for the di-sulphonated molecule at the low molar ratios
(Figure 4B), but at the highest (9:1) no ﬁbre was evident,
rendering instead an amorphous aggregate, similar to that
reported (18) when WH1-A31V is incubated in the
absence of dsDNA (Figure 4A). In conclusion, targeting
with acidic indigo derivatives the binding site of eﬀector
dsDNA molecules in WH1-A31V is an eﬃcient way to
inhibit the assembly of the latter into amyloid ﬁbres.
DISCUSSION
A central issue in current protein science is the survey of
factors promoting amyloidogenesis. Natural and synthetic
Figure 4. S2/S4-indigos inhibit DNA-promoted WH1-A31V amyloidogenesis according to TEM (magniﬁcation bars: 200nm). (A) Control aggregates
(top) and ﬁbres (bottom) observed after 1 month incubation in the absence or presence of opsp dsDNA, respectively (18). (B) Samples including
three diﬀerent indigoid-to-protein (and dsDNA) molar ratios. S2 (top row) and, specially, S4-indigo (bottom row) lead to shorter and thinner ﬁbres
and, at the highest concentration tested, S4-indigo yields protein aggregates alike those found in the absence of DNA (see A).
Figure 3. Thermodynamic characterization (ITC) of the binding of
S4-indigo to WH1-WT. (A) Binding isotherm for the titration of
protein (98mM) with the ligand (1.41mM reservoir; concentration
interval: 7.8–172mM). (B) Integration of data plotted against the molar
ratio between S4-ligand and WH1 (as monomers). The curve ﬁts to a
major binding site (#1) with a secondary site (#2) becoming evident at
higher dye:protein ratios.
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found to enhance the assembly of the mammalian PrP into
amyloids (3–11). Similarly, the dimeric WH1 domain of
the bacterial plasmid replication protein RepA, besides its
role in regulating replication initiation by the full length
protein (13; Figure 5A), assembles into distinct amyloid
aggregates, including spherulites and ordered ﬁbres, upon
transient binding to small speciﬁc dsDNA sequences (18)
(Figure 5B). These are not constituents of the ﬁnal
aggregated particles which are mainly (if not exclusively)
formed by RepA-WH1 (18), in agreement with the protein
only nature of any amyloid structure (1,2), assembled
through an amyloidogenic motif located opposite to the
DNA-binding surface in WH1 structure (17).
We have found that di- and tetra-sulphonated deriva-
tives of the indigo stain dock at the dsDNA recognition
surface in RepA-WH1 (17), thus competing protein–DNA
interactions and subsequently inhibiting the assembly of
WH1 into amyloid ﬁbres. The interaction of a single
S4-indigo molecule with a WH1 dimer primarily occurs
through a binding site exhibiting micromolar aﬃnity.
It can be competed by increasing the ionic strength
(becoming undetectable by ITC at 0.1M Na2SO4; data not
shown), as expected from the predicted major enthalpic
Figure 5. A scheme of the conformational transactions experienced by pPS10 RepA protein. (A) For the whole RepA protein, the balance between
dimers (dRepA) and monomers (mRepA) is modulated by the target iteron DNA sequence (blue). WH2 binding implies dimer dissociation and
a local secondary structure conversion (a!b) in WH1 (13,16), which becomes a metastable intermediate (the unbound domain depicted as a star) (14).
This short-lived species is stabilized through WH1 binding to the iteron (15). On the contrary, dRepA can bind to the operator DNA sequence
(red) without altering its association state and with minor eﬀects (if any) on the structure of the WH1 domain (represented as a cube). Overall,
the binding to the iteron sequence deﬁnes an irreversible refolding trajectory for WH1. (B) The extent of the remodelling exerted by the core of
those target DNA sequences in the WH1 domain, in combination with the amyloidogenic enhancer A31V mutation, lead to the assembly of the
protein into either ordered ﬁbres, or spheroids, or large and irregular aggregates (18). Their formation can be interpreted as paralleling the
pathway outlined in (A). As it is shown in this article, binding of sulphonated indigoids (S4 molecule depicted) to WH1 dimers competes with
dsDNA binding, thus inhibiting amyloidogenesis and leading to small, grainy protein aggregates.
2254 Nucleic Acids Research, 2008, Vol. 36, No. 7contribution of electrostatic interactions to G. However,
the sulphonated indigoids can still exert their inhibitory
action on WH1 amyloidogenesis during the prolonged
incubations required for nucleation and growth of the
protein ﬁbres. The interaction of S4-indigo with WH1
dimers is speciﬁc, albeit at high ligand concentrations
multiple molecules bind non-speciﬁcally. This would be
related to the kind of large micellar complexes described
for some hits coming out frequently in high throughput
screenings of diverse protein targets (25).
Our results suggest that the promoting action of
dsDNA on WH1 amyloidogenesis does not merely consist
in shielding the electropositive patch in the protein (17) to
allow for ﬁbre assembly (18), since the indigoids would
have the same eﬀect and yet they do not yield ordered
ﬁbres, but increasingly disordered structures and, ﬁnally,
amorphous aggregates. Thus, transient interactions with
operator dsDNA should promote in WH1 some structural
alteration that must be crucial for amyloidogenesis,
contributing to the changes in the CD spectra previously
attributed just to the assembly of the amyloidogenic
stretch into a cross-b spine (18).
Many small molecules, including a number of indol
derivatives (26), have been described to directly interfere
with protein aggregation through amyloidogenic stretches
(19,20). However, to our knowledge those reported here
are the ﬁrst targeting a protein region not directly
assembled into a cross-b structure, but a site recognized
by an allosteric eﬀector of protein amyloidogenesis. The
sulphonated indigoids, due to their speciﬁcity for the
dsDNA binding pocket in RepA-WH1, are unlikely to
have general applicability for other amyloidogenic pro-
teins or even to bind to close RepA homologues, such
as the dimers of the RepE protein, which do not bind
to operator DNA through the WH1 domain (27). This is
probably due to its reduced electropositive character,
derived from the lack of basic residues equivalent to
Arg81, 91 and 93 in RepA. The S2/S4-indigos also
have the intrinsic limitations to membrane permeability
derived from their acidic character. Notwithstanding, this
work illustrates both the contribution of co-factors
(dsDNA) to the assembly of protein amyloids and the
feasibility of targeting their binding sites to design anti-
amyloidogenic drugs.
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